Active Infection & Immunity Brain & Nervous System

Perturbing the crosstalk between microglia and neurons uncovers mechanisms underpinning neuronal damage and repair in HIV central nervous system infection

In plain English

AI plain-English summary

HIV hides in the brain’s immune cells, where it damages neurons and can re-emerge if treatment stops. This project will grow miniature 3D brain models in the lab, co-culturing human neurons with microglia—the brain’s resident immune cells—to watch exactly how the virus disrupts the chemical signals that normally keep neurons healthy. The problem is that standard HIV drugs struggle to reach the brain, leaving a hidden viral reservoir. This reservoir causes brain injury in adults, risks viral rebound if therapy is interrupted, and may harm brain development in babies born to mothers with HIV. Current treatments cannot clear this reservoir, partly because scientists do not fully understand how HIV-infected microglia damage neurons. If this research succeeds, it will identify specific molecular pathways—such as altered cytokine levels, calcium influx, or epigenetic changes like histone acetylation—that could be targeted with new drugs. The work is fundamental science: it aims to map host-pathogen interactions in the brain. A deeper understanding of these mechanisms could eventually lead to therapies that protect neurons from HIV-related damage, or prevent neurodevelopmental problems in children, even if a complete cure remains distant.

View original technical description
A central nervous system HIV-1 latent reservoir occurs due to poor drug penetration and weakened immune surveillance. Implications are: 1) aetiology in HIV-associated brain injury (HABI), 2) viral rebound if treatment ceases, 3) barrier to cure and 4) implications for neurodevelopment in babies born to mothers with HIV. Microglia are immune cell types in the brain. Regulated crosstalk between microglia and developing neurons is essential for normal neuronal development. I hypothesise that disruption of this crosstalk by either HIV replication in microglia and consequent neuroinflammation or through interaction with C-C chemokine receptor type 5 expressed on various brain cells or other CD4-independent pathways, causes aberrant intracellular signalling, which alters cytokine and chemokine levels, leading to inflammation, calcium influx and apoptosis in neurons. Additionally, this crosstalk can be perturbed by epigenetic modifications including histone acetylation and methylation. Building upon research in my PhD, I will utilise biobanked specimens from characterised clinical cohorts and physiologically relevant models; 2D iPSC-derived microglia/neuron co-cultures and 3D brain organoids, as well as develop new skills in multiomic approaches, to uncover host-pathogen interactions underlying HIV neuroinflammation. This will give me a platform to develop an independent research program on therapeutic targets for HABI and viral-mediated neurodevelopmental problems.

View the original record at the funder ↗

Researchers

Dami Collier (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Using iPSC variation to define HIV-1 regulatory networks
Investigating the mechanisms involved in HIV infection and cerebral endothelial dysfunction in a 3D human brain neurovascular spheroid.
Spatial Mapping of the HIV Brain Reservoir and Genomic Changes in Health and Neurological Diseases
HIV-1 mediated reprogramming of T cell gene expression networks
Central nervous system compartmentalisation and drug resistance in HIV-1 sub-type C infection

Original classification

Wellcome Accelerator Awards

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.